Literature DB >> 28162019

Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia.

Angela Maria Savino1, Shai Izraeli2.   

Abstract

Entities:  

Keywords:  Acute lymphoblastic leukemia; CRLF2; JAK-STAT; TSLP; interleukin-7

Mesh：

Substances：

Year:  2017        PMID： 28162019     DOI： 10.1080/17474086.2017.1292121

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN： 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  2 in total

1.  IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.

Authors:  Sara González-García; Marta Mosquera; Patricia Fuentes; Tiziana Palumbo; Adela Escudero; Antonio Pérez-Martínez; Manuel Ramírez; Anne E Corcoran; Maria L Toribio
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

2.  IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Ameera Alsadeq; Lennart Lenk; Anila Vadakumchery; Antony Cousins; Christian Vokuhl; Ahmad Khadour; Fotini Vogiatzi; Felix Seyfried; Lueder-Hinrich Meyer; Gunnar Cario; Elias Hobeika; Klaus-Michael Debatin; Christina Halsey; Martin Schrappe; Denis M Schewe; Hassan Jumaa
Journal:  Blood       Date:  2018-08-28       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.